Pharmacokinetic Study With Repeated Doses of Stalevo
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show that higher minimum concentration values are obtained
following repeated doses of Stalevo 4 times daily compared to lecodopa/carbidopa treatment
with corresponding dosing regimen.